Literature DB >> 33539685

Production of Class II MHC Proteins in Lentiviral Vector-Transduced HEK-293T Cells for Tetramer Staining Reagents.

Richard A Willis1,2, Vasanthi Ramachandiran1,2, John C Shires1,2, Ge Bai1,2, Kelly Jeter1,2, Donielle L Bell1,2, Lixia Han1,2, Tamara Kazarian1,2, Kyla C Ugwu1,2, Oskar Laur3,4, Susana Contreras-Alcantara1,2, Dale L Long1,2, John D Altman1,2,3,5.   

Abstract

Class II major histocompatibility complex peptide (MHC-IIp) multimers are precisely engineered reagents used to detect T cells specific for antigens from pathogens, tumors, and self-proteins. While the related Class I MHC/peptide (MHC-Ip) multimers are usually produced from subunits expressed in E. coli, most Class II MHC alleles cannot be produced in bacteria, and this has contributed to the perception that MHC-IIp reagents are harder to produce. Herein, we present a robust constitutive expression system for soluble biotinylated MHC-IIp proteins that uses stable lentiviral vector-transduced derivatives of HEK-293T cells. The expression design includes allele-specific peptide ligands tethered to the amino-terminus of the MHC-II β chain via a protease-cleavable linker. Following cleavage of the linker, HLA-DM is used to catalyze efficient peptide exchange, enabling high-throughput production of many distinct MHC-IIp complexes from a single production cell line. Peptide exchange is monitored using either of two label-free methods, native isoelectric focusing gel electrophoresis or matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry of eluted peptides. Together, these methods produce MHC-IIp complexes that are highly homogeneous and that form the basis for excellent MHC-IIp multimer reagents.
© 2021 Wiley Periodicals LLC. Basic Protocol 1: Lentivirus production and expression line creation Support Protocol 1: Six-well assay for estimation of production cell line yield Support Protocol 2: Universal ELISA for quantifying proteins with fused leucine zippers and His-tags Basic Protocol 2: Cultures for production of Class II MHC proteins Basic Protocol 3: Purification of Class II MHC proteins by anti-leucine zipper affinity chromatography Alternate Protocol 1: IMAC purification of His-tagged Class II MHC Support Protocol 3: Protein concentration measurements and adjustments Support Protocol 4: Polishing purification by anion-exchange chromatography Support Protocol 5: Estimating biotinylation percentage by streptavidin precipitation Basic Protocol 4: Peptide exchange Basic Protocol 5: Analysis of peptide exchange by matrix-assisted laser desorption/ionization (MALDI) mass spectrometry Alternate Protocol 2: Native isoelectric focusing to validate MHC-II peptide loading Basic Protocol 6: Multimerization Basic Protocol 7: Staining cells with Class II MHC tetramers. © 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  Class II MHC multimers; Class II MHC tetramers; antigen-specific T cells; flow cytometry; lentiviral transduction; protein engineering; protein expression; protein purification

Mesh:

Substances:

Year:  2021        PMID: 33539685      PMCID: PMC7880703          DOI: 10.1002/cpz1.36

Source DB:  PubMed          Journal:  Curr Protoc        ISSN: 2691-1299


  54 in total

1.  Peptide 'Velcro': design of a heterodimeric coiled coil.

Authors:  E K O'Shea; K J Lumb; P S Kim
Journal:  Curr Biol       Date:  1993-10-01       Impact factor: 10.834

2.  Detection of Intracellular Cytokines by Flow Cytometry.

Authors:  Yuzhi Yin; Alyssa Mitson-Salazar; Calman Prussin
Journal:  Curr Protoc Immunol       Date:  2015-08-03

3.  Generation of peptide MHC class I monomers and multimers through ligand exchange.

Authors:  Mireille Toebes; Boris Rodenko; Huib Ovaa; Ton N M Schumacher
Journal:  Curr Protoc Immunol       Date:  2009-11

4.  Production of soluble MHC class II proteins with covalently bound single peptides.

Authors:  H Kozono; J White; J Clements; P Marrack; J Kappler
Journal:  Nature       Date:  1994-05-12       Impact factor: 49.962

5.  Formation of functional peptide complexes of class II major histocompatibility complex proteins from subunits produced in Escherichia coli.

Authors:  J D Altman; P A Reay; M M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

6.  Negative selection and peptide chemistry determine the size of naive foreign peptide-MHC class II-specific CD4+ T cell populations.

Authors:  H Hamlet Chu; James J Moon; Andrew C Kruse; Marion Pepper; Marc K Jenkins
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

7.  New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation.

Authors:  Elise Landais; Pablo A Romagnoli; Adam L Corper; John Shires; John D Altman; Ian A Wilson; K Christopher Garcia; Luc Teyton
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

Review 8.  More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers.

Authors:  Garry Dolton; Katie Tungatt; Angharad Lloyd; Valentina Bianchi; Sarah M Theaker; Andrew Trimby; Christopher J Holland; Marco Donia; Andrew J Godkin; David K Cole; Per Thor Straten; Mark Peakman; Inge Marie Svane; Andrew K Sewell
Journal:  Immunology       Date:  2015-09       Impact factor: 7.215

9.  Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II.

Authors:  A Sette; S Southwood; J Miller; E Appella
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

10.  Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules.

Authors:  C A Scott; K C Garcia; F R Carbone; I A Wilson; L Teyton
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  1 in total

1.  Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles.

Authors:  Aniuska Becerra-Artiles; J Mauricio Calvo-Calle; Mary Dawn Co; Padma P Nanaware; John Cruz; Grant C Weaver; Liying Lu; Catherine Forconi; Robert W Finberg; Ann M Moormann; Lawrence J Stern
Journal:  Cell Rep       Date:  2022-05-27       Impact factor: 9.995

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.